117 related articles for article (PubMed ID: 21774947)
1. Dopamine-depletion and increased α-synuclein load induce degeneration of cortical cholinergic fibers in mice.
Szego ÉM; Gerhardt E; Outeiro TF; Kermer P
J Neurol Sci; 2011 Nov; 310(1-2):90-5. PubMed ID: 21774947
[TBL] [Abstract][Full Text] [Related]
2. Impairment of the septal cholinergic neurons in MPTP-treated A30P α-synuclein mice.
Szegő ÉM; Outeiro TF; Kermer P; Schulz JB
Neurobiol Aging; 2013 Feb; 34(2):589-601. PubMed ID: 22579457
[TBL] [Abstract][Full Text] [Related]
3. A30P α-synuclein impairs dopaminergic fiber regeneration and interacts with L-DOPA replacement in MPTP-treated mice.
Szego ÉM; Gerhardt E; Kermer P; Schulz JB
Neurobiol Dis; 2012 Jan; 45(1):591-600. PubMed ID: 22001606
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP.
Dong Z; Ferger B; Feldon J; Büeler H
J Neurobiol; 2002 Oct; 53(1):1-10. PubMed ID: 12360578
[TBL] [Abstract][Full Text] [Related]
5. Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions.
Gibrat C; Saint-Pierre M; Bousquet M; Lévesque D; Rouillard C; Cicchetti F
J Neurochem; 2009 Jun; 109(5):1469-82. PubMed ID: 19457163
[TBL] [Abstract][Full Text] [Related]
6. Selective alterations of gene expression in mice induced by MPTP.
Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
[TBL] [Abstract][Full Text] [Related]
7. Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice.
Nieto M; Gil-Bea FJ; Dalfó E; Cuadrado M; Cabodevilla F; Sánchez B; Catena S; Sesma T; Ribé E; Ferrer I; Ramírez MJ; Gómez-Isla T
Neurobiol Aging; 2006 Jun; 27(6):848-56. PubMed ID: 16006012
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein 70 kDa over-expression and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigrostriatal degeneration in mice.
Gao L; Díaz-Martín J; Dillmann WH; López-Barneo J
Neuroscience; 2011 Oct; 193():323-9. PubMed ID: 21782904
[TBL] [Abstract][Full Text] [Related]
9. Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein.
Marxreiter F; Nuber S; Kandasamy M; Klucken J; Aigner R; Burgmayer R; Couillard-Despres S; Riess O; Winkler J; Winner B
Eur J Neurosci; 2009 Mar; 29(5):879-90. PubMed ID: 19291219
[TBL] [Abstract][Full Text] [Related]
10. Cystamine prevents MPTP-induced toxicity in young adult mice via the up-regulation of the brain-derived neurotrophic factor.
Gibrat C; Bousquet M; Saint-Pierre M; Lévesque D; Calon F; Rouillard C; Cicchetti F
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):193-203. PubMed ID: 19913065
[TBL] [Abstract][Full Text] [Related]
11. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.
Katila N; Bhurtel S; Shadfar S; Srivastav S; Neupane S; Ojha U; Jeong GS; Choi DY
Neuropharmacology; 2017 Oct; 125():396-407. PubMed ID: 28807678
[TBL] [Abstract][Full Text] [Related]
12. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
Gibbs RB
Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764
[TBL] [Abstract][Full Text] [Related]
13. Neurotrophic and neurorescue effects of Echinacoside in the subacute MPTP mouse model of Parkinson's disease.
Zhao Q; Gao J; Li W; Cai D
Brain Res; 2010 Jul; 1346():224-36. PubMed ID: 20478277
[TBL] [Abstract][Full Text] [Related]
14. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
Schell H; Hasegawa T; Neumann M; Kahle PJ
Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
[TBL] [Abstract][Full Text] [Related]
15. The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain.
Domenger D; Dea D; Theroux L; Moquin L; Gratton A; Poirier J
Exp Neurol; 2012 Jan; 233(1):513-22. PubMed ID: 22155743
[TBL] [Abstract][Full Text] [Related]
16. Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model.
Bousquet M; Gibrat C; Saint-Pierre M; Julien C; Calon F; Cicchetti F
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1401-8. PubMed ID: 19632286
[TBL] [Abstract][Full Text] [Related]
17. Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism.
Faherty CJ; Raviie Shepherd K; Herasimtschuk A; Smeyne RJ
Brain Res Mol Brain Res; 2005 Mar; 134(1):170-9. PubMed ID: 15790541
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
Shin JY; Park HJ; Ahn YH; Lee PH
J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
[TBL] [Abstract][Full Text] [Related]
19. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.
Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL
Neurotoxicology; 2004 Sep; 25(5):761-9. PubMed ID: 15288507
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
Poon HF; Frasier M; Shreve N; Calabrese V; Wolozin B; Butterfield DA
Neurobiol Dis; 2005 Apr; 18(3):492-8. PubMed ID: 15755676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
